ASSIST: A Study in SurvIvors of Type B Aortic Dissection Undergoing Stenting

Sponsor
JOTEC GmbH (Industry)
Overall Status
Completed
CT.gov ID
NCT01407159
Collaborator
(none)
40
15
26
2.7
0.1

Study Details

Study Description

Brief Summary

Cohort study according to national regulatory guidelines: Non-interventional, observational cohort study. Pair-matched comparison with patients chosen from historical series.

To evaluate the clinical and technical success as well as the safety and feasibility of the E-XL aortic stent used in complicated type B aortic dissection in addition to a classic stentgraft in a single procedure.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    40 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    ASSIST - A Study in SurvIvors of Type B Aortic Dissection Undergoing Stenting
    Study Start Date :
    Nov 1, 2011
    Actual Primary Completion Date :
    Dec 1, 2013
    Actual Study Completion Date :
    Jan 1, 2014

    Arms and Interventions

    Arm Intervention/Treatment
    Thoracic Stentgraft plus E-XL

    male and female patients with complicated type B aortic dissection involving the infra-diaphragmatic aorta treated with any thoracic stentgraft extended by the E-XL aortic stent

    Control group

    historical control group fulfilling the following criteria: Age +/- 3 years Sex matched Same follow-up period

    Outcome Measures

    Primary Outcome Measures

    1. To evaluate the clinical and technical success as well as the safety and feasibility of the E-XL aortic stent used in complicated type B aortic dissection in addition to a classic thoracic stent-graft in a single procedure. [February 2014]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    The clinical records of the patients mus support the following criteria:
    • Age > 18 years

    • Type B dissection with expanding false lumen eligible for endovascular treatment which occured within 90 days prior to implantation

    • The endovascular treatment may be associated with a complementary surgical operation

    • The total diameter of the dissected aortic segment should not surpass 6cm, and have increased between 0.5 and 1cm within 1 month, prior to implantation

    • Visceral arteries involvement, i.e. perfusion of side branches via true or false lumen of type B dissection

    • Aortic kinking < 90°

    • The patient must be available for the appropriate follow-up times for the duration of the study

    • Informed consent from patient or authorized relative

    The data of whose patients clinical records confirm one of the following conditions will not be considered in this study:

    • Patients with a contraindication as indicated in the instruction for use

    • Patients with chronic thrombocytopenia or ongoing anticoagulation

    • Patients with renal failure and/or creatinine >2.4mg/dl immediately before the intervention

    • Patients in whom the false lumen is completely thrombosed

    • Patients with ongoing infection

    • Patients with ongoing cancer

    • Patients who are enrolled in a clinical study

    • Aortic landing zone diameter over 40 mm

    • Potentially emboligenic iliac and aortic atheroma lesions

    • Associated pathology with life expectancy of less than 24 months

    • Unstable infectious syndrome

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Klinikum Augsburg Augsburg Germany
    2 German Heart Center Berlin Germany 13353
    3 University Hospital Essen Germany 45147
    4 University Hospital Freiburg Germany
    5 Hannover Medical School Hanover Germany 30625
    6 University Hospital Jena Germany 07747
    7 St. Franziskus Hospital Muenster Germany 48145
    8 University Hospital Munich Grosshadern Munich Germany
    9 University Hospital Rostock Germany
    10 Department of Radiologia Toracica e Vascolare Bologna Italy 40138
    11 IRCCS Policlinico San Donato Milano Milan Italy 20097
    12 Krakowski Szpital Specjalistyczny im. Jana Pawła II Kraków Poland 31-202
    13 Samodzielny Publiczny Szpital Kliniczny Nr 1 Lublin Poland 20-081
    14 Thorax Insitute, Hospital Clinic, University of Barcelona Barcelona Spain 08036
    15 Hospital Clinico Universitario de Valladolid Valladolid Spain 47005

    Sponsors and Collaborators

    • JOTEC GmbH

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    JOTEC GmbH
    ClinicalTrials.gov Identifier:
    NCT01407159
    Other Study ID Numbers:
    • ASSIST
    First Posted:
    Aug 2, 2011
    Last Update Posted:
    Apr 28, 2014
    Last Verified:
    Apr 1, 2014

    Study Results

    No Results Posted as of Apr 28, 2014